Rulemaking History for OTC Internal Analgesic Drug Products

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research

Rulemaking History for OTC Internal Analgesic Drug Products
View by Date

Final Monograph (21 CFR part 343):
Internal Analgesic, Antipyretic, Antirheumatic Drug Products for Over-the-Counter Human Use

OTC Internal Analgesic Drug Products found on this page:

Note: This page links to PDF files which require the free Adobe Acrobat Reader.

**Internal Analgesic Drug Products: Original Active Ingredients and Labeling**
Advance Notice Of Proposed Rulemaking	Date	FR Citation
Advance Notice of Proposed Rulemaking	7/8/1977	42FR35346
Extension of Comment Period	10/4/1977	42FR53980
Extension of Comment Period	1/6/1978	43FR1100
Reopening of Administrative Record	3/21/1980	45FR18401
Proposed Rule	Date	FR Citation
Tentative Final Monograph	11/16/1988	53FR46204
Correction	2/3/1989	55FR5576
Extension of Comment Period	1/16/1990	55FR1472
Notice: Advisory Committee meeting on indications	7/11/1994	59FR35375
Request for Comments	7/22/1994	59FR37421
Notice: Amendment of Advisory Committee meeting agenda	8/16/1994	59FR42060
Notice: Allows marketing of antacid and acetaminophen combinations	2/5/1992	57FR4456
Correction	2/20/1992	57FR6165
Correction	2/28/1992	57FR6892
Final Rule	Date	FR Citation
Notice: Withdraws 4/5/1967 Proposed Rule (withdraws obsolete proposed rules)	6/5/1984	49FR23194
Final Rule: Classifies atropine and ephedrine ingredients as nonmonograph	8/24/1998	63FR44996

**Internal Analgesic Drug Products: Nonmonograph Ingredients**
Proposed Rule	Date	FR Citation
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph	8/25/1992	57FR38568
Correction	9/8/1992	57FR40944
Technical Amendment: Correct an ingredient name	10/1/1992	57FR45295
Correction	11/9/1992	57FR53300
Final Rule	Date	FR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph	5/10/1993	58FR27636

**Internal Analgesic Drug Products: Ibuprofen**
Proposed Rule	Date	FR Citation
Proposed Rule: Adds ibuprofen as GRASE active ingredient	8/21/2002	67FR54139
Extension of Comment Period	6/4/2003	68FR33429

**Internal Analgesic Drug Products: Professional Labeling**
Proposed Rule	Date	FR Citation
Proposed Rule: Aspirin professional labeling (suspected myocardial infarction)	6/13/1996	61FR30002
Final Rule	Date	FR Citation
Final Rule	10/23/1998	63FR56802
Technical Amendment	9/14/1999	64FR49652

**Internal Analgesic Drug Products: Related FTC Rulemakings**
Proposed Rule	Date	FR Citation
Proposed Rule: Prohibits comparative effectiveness claims	4/29/1983	48FR19360
Final Rule	Date	FR Citation
Final Rule: Prohibits comparative effectiveness claims (Bristol Myers)	7/29/1983	48FR34419
Final Rule: Prohibits comparative effectiveness claims (Sterling Drug)	7/29/1983	48FR34424

**Internal Analgesic Drug Products: Phenacetin**
Proposed Rule	Date	FR Citation
Notice: Hearing on NDA withdrawal	8/10/1982	47FR34636
Final Rule	Date	FR Citation
Notice: NDA withdrawal	10/5/1983	48FR45466

**Internal Analgesic Drug Products: Alcohol Warning**
Proposed Rule	Date	FR Citation
Proposed Rule: Requires warning	11/14/1997	62FR61041
Final Rule	Date	FR Citation
Final Rule	10/23/1998	63FR56789
Notice: Extension of compliance date	3/17/1999	64FR13066

**Internal Analgesic Drug Products: Reye's Syndrome Warning**
Advance Notice Of Proposed Rulemaking	Date	FR Citation
Advance Notice of Proposed Rulemaking	12/28/1982	47FR57886
Correction	1/21/1983	48FR2789
Proposed Rule	Date	FR Citation
Proposed Rule: Requires warning for aspirin	12/17/1985	50FR51400
Proposed Rule: Makes warning permanent requirement	1/22/1988	53FR1796
Proposed Rule: Requires warning for nonaspirin salicylate-containing drugs	10/20/1993	58FR54228
Final Rule	Date	FR Citation
Final Rule: Requires warning for aspirin	3/7/1986	51FR8180
Final Rule: Makes warning permanent requirement	6/9/1988	53FR21633
Correction	6/30/1988	53FR24830
Final Rule: Requires warning for nonaspirin salicylate-containing drugs	4/17/2003	68FR18861

**Internal Analgesic Drug Products: Upset Stomach/ Overindulgence**
Proposed Rule	Date	FR Citation
Proposed Rule: Adds indication	12/24/1991	56FR66762
Proposed Rule: Sodium bicarbonate stomach rupture (overindulgence)	2/2/1994	59FR5068
Reopening of Comment Period	4/19/1994	59FR18507

**Internal Analgesic Drug Products: Stomach Bleeding & Liver Warning**
Proposed Rule	Date	FR Citation
Proposed Rule: Adds liver and stomach bleeding warnings, removes alcohol warning, and adds additional NSAID labeling	12/26/2006	71FR77314

Date created: December 28, 2006; Last updated: May 4, 2007